Status:
COMPLETED
Coffee Interaction With the Antihypertensive Drug Felodipine
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Food-Drug Interactions
Eligibility:
All Genders
30-65 years
Phase:
PHASE1
Brief Summary
Coffee is a globally popular beverage. More than half of the United States population spends an estimated $ 40 billion on the purchase of coffee each year. Personal consumption habits can vary. For ex...
Eligibility Criteria
Inclusion
- healthy (normal physical exam, blood clinical chemistry)
- willingly signs ethics approved informed consent form
Exclusion
- history of cardiac, renal, hepatic or gastrointestinal disease or substance abuse
- significant illness within 2 weeks of starting study
- history of allergy to felodipine , tablet ingredients or dihydropyridines
- routinely taking prescription or OTC drugs or natural health products
- received an investigational drug withing the previous 4 weeks
- females who are pregnant or breast-feeding
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT02232269
Start Date
February 1 2012
End Date
May 1 2013
Last Update
August 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Victoria Clinical Trials Centre
London, Ontario, Canada